HLS tries to convince backers of survival prognosis

Huntingdon Life Sciences is launching a charm offensive to convince backers that the emergency cash infusion by an unnamed US investor will guarantee the drugs-testing company's long-term survival.

A rescue package at the eleventh hour saved the company from shutdown